Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1310-1314
Published online before print February 12, 2009, doi: 10.1161/STROKEAHA.108.531400
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1310    most recent
STROKEAHA.108.531400v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riedel, C. H.
Right arrow Articles by Jansen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riedel, C. H.
Right arrow Articles by Jansen, O.
Related Collections
Right arrow Arterial thrombosis
Right arrow Other Treatment
Right arrow Acute Cerebral Infarction
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Thrombolysis
Right arrow Angioplasty and Stenting

(Stroke. 2009;40:1310.)
© 2009 American Heart Association, Inc.


Original Contributions

Subacute Stent Thrombosis in Intracranial Stenting

Christian H. Riedel, MD; Marc Tietke, MD; Karsten Alfke, MD; Robert Stingele, MD Olav Jansen, MD

From the Departments of Neuroradiology (C.H.R., M.T., K.A., O.J.) and Neurology (R.S.), UKS-H, Campus Kiel, Kiel, Germany.

Correspondence to Christian H. Riedel, Department of Neuroradiology, UKS-H, Campus Kiel, Schittenhelmstrasse 10, 24105 Kiel, Germany. E-mail address c.riedel{at}neurorad.uni-kiel.de

Background and Purpose— We sought to determine the safety of intracranial stenting with respect to subacute stent thrombosis in patients being treated with standardized antiplatelet therapy.

Methods— We retrospectively evaluated the outcome of primary intracranial stenting of atherosclerotic stenoses and of stenting in coil embolization procedures in 67 patients. We focused on those cases that led to subacute stent thrombosis even though the patients had been treated with standardized antiplatelet therapy before, during, and after stent placement. Patient age ranged from 19 to 78 years. In 33 patients, stents were placed for treatment of atherosclerotic stenoses; in the remaining 34 patients, stents were placed to assist coiling of aneurysms. The patients in this study were treated between January 2003 and August 2007.

Results— Of the total 67 patients initially treated successfully by intracranial stenting, 7 patients developed subacute stent thrombosis. Of these 7 patients, 3 received stent placement into the basilar artery because of an underlying stenosis; in 1 patient, a stenosis of the M1 segment of the middle cerebral artery was treated. In 3 patients, aneurysms of the anterior cerebral artery, the posterior inferior cerebellar artery, and the basilar artery were treated by stent-assisted coil embolization. In 4 of the 7 patients with subacute thrombosis, recanalization of stents by local application of recombinant tissue-type plasminogen activator was successful.

Conclusions— Intracranial stenting can lead to subacute stent thrombosis, even in patients who are treated with standardized antiplatelet therapy. Such complications have been described for patients after coronary artery stenting, but to our knowledge, no one has reported on a comparable number of cases of intracranial stenting procedures. In certain clinical scenarios, local thrombolysis with recombinant tissue-type plasminogen activator is an important treatment option to deal with subacute stent thrombosis.


Key Words: antiplatelet drugs • antithrombotics • imaging • interventional neuroradiology • intracranial aneurysm • intracranial stenosis • neuroradiology • stenting • stents • thrombolysis • thrombosis